Ignite Creation Date:
2024-05-05 @ 9:33 PM
Last Modification Date:
2024-10-26 @ 10:06 AM
Study NCT ID:
NCT00914186
Status:
COMPLETED
Last Update Posted:
2011-12-01
First Post:
2009-05-28
Brief Title:
Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus POC
Sponsor:
Taisho Pharmaceutical RD Inc
Organization:
Taisho Pharmaceutical RD Inc
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Vehicle-Controlled Study of the Efficacy Safety and Tolerability of TS-022 in Adult Patients With a Diagnosis of Atopic Dermatitis AD With Moderate to Very Severe Pruritus
Status:
COMPLETED
Status Verified Date:
2011-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose and primary objectives of this study are to evaluate the efficacy safety and tolerability of TS-022 in adults with atopic dermatitis who have moderate to very severe pruritus itching following a 28-day regimen of twice-daily topical application
Detailed Description:
none provided
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None